Signal The quantum drug discovery market is said to have roughly doubled in five years

Summary

The report states that the market for quantum drug discovery has roughly doubled in value over the last five years. It interprets this growth as genuine investment aimed at deployment rather than speculative positioning. The pharmaceutical industry, in the report's words, has taken notice of the technology. Recent engineering gains, including better error correction and hybrid quantum-classical systems, have made the tools more reliable and easier to fit into existing workflows. Partnerships such as IBM with Moderna and Pasqal with Qubit Pharmaceuticals are cited as concrete examples. The outlook adds that rare and orphan diseases are now the fastest-growing segment of quantum-enabled drug discovery.